GABAB receptor (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "GABAB receptor" in Czech language version.

refsWebsite
Global rank Czech rank
4th place
8th place
2nd place
4th place
18th place
99th place
5th place
3rd place
9,207th place
6,360th place
6,663rd place
4,114th place

aspetjournals.org

molpharm.aspetjournals.org

  • Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, Kaupmann K. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharmacol.. November 2001, s. 963–71. Dostupné online. DOI 10.1124/mol.60.5.963. PMID 11641424. 

bristol.ac.uk

doi.org

dx.doi.org

  • Chen K, Li HZ, Ye N, Zhang J, Wang JJ. Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro. Brain Res Bull. 2005, s. 310–8. DOI 10.1016/j.brainresbull.2005.07.004. PMID 16182939. 
  • HYLAND, NP; CRYAN, JF. A Gut Feeling about GABA: Focus on GABA(B) Receptors.. Frontiers in Pharmacology. 2010, s. 124. DOI 10.3389/fphar.2010.00124. PMID 21833169. 
  • HILL, DR; BOWERY, NG. 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain.. Nature. 12 March 1981, s. 149–52. DOI 10.1038/290149a0. PMID 6259535. Bibcode 1981Natur.290..149H. 
  • Dzitoyeva S, Dimitrijevic N, Manev H. Gamma-aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: adult RNA interference and pharmacological evidence. Proc Natl Acad Sci USA. 2003, s. 5485–90. DOI 10.1073/pnas.0830111100. PMID 12692303. Bibcode 2003PNAS..100.5485D. 
  • Dimitrijevic N, Dzitoyeva S, Satta R, Imbesi M, Yildiz S, Manev H. Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB). Eur J Pharmacol. 2005, s. 246–52. DOI 10.1016/j.ejphar.2005.07.016. PMID 16129424. 
  • Manev H, Dimitrijevic N. Drosophila model for in vivo pharmacological analgesia research. Eur J Pharmacol. 2004, s. 207–8. DOI 10.1016/j.ejphar.2004.03.030. PMID 15140638. 
  • Dzitoyeva S, Gutnov A, Imbesi M, Dimitrijevic N, Manev H. Developmental role of GABAB(1) receptors in Drosophila. Brain Res Dev Brain Res. 2005, s. 111–4. DOI 10.1016/j.devbrainres.2005.06.005. PMID 16054235. 
  • Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, Kaupmann K. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharmacol.. November 2001, s. 963–71. Dostupné online. DOI 10.1124/mol.60.5.963. PMID 11641424. 
  • Adams CL, Lawrence AJ. CGP7930: a positive allosteric modulator of the GABAB receptor. CNS Drug Rev. 2007, s. 308–16. DOI 10.1111/j.1527-3458.2007.00021.x. PMID 17894647. 
  • Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A. Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J. Pharmacol. Exp. Ther.. July 2008, s. 306–14. DOI 10.1124/jpet.108.139204. PMID 18445779. 
  • Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, Kaupmann K. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J. Pharmacol. Exp. Ther.. October 2003, s. 322–30. DOI 10.1124/jpet.103.053074. PMID 12954816. 
  • Giotti A, Luzzi S, Spagnesi S, Zilletti L. Homotaurine: a GABAB antagonist in guinea-pig ileum.. Br. J. Pharmacol.. 1983, s. 855–62. DOI 10.1111/j.1476-5381.1983.tb10529.x. PMID 6652358. 
  • Kimura T, Saunders PA, Kim HS, Rheu HM, Oh KW, Ho IK. Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors. General Pharmacology. 1994, s. 193–9. DOI 10.1016/0306-3623(94)90032-9. PMID 8026706. 
  • Froestl W, Gallagher M, Jenkins H, Madrid A, Melcher T, Teichman S, Mondadori CG, Pearlman R. SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochemical Pharmacology. October 2004, s. 1479–87. DOI 10.1016/j.bcp.2004.07.030. PMID 15451390. 

harvard.edu

adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

  • Chen K, Li HZ, Ye N, Zhang J, Wang JJ. Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro. Brain Res Bull. 2005, s. 310–8. DOI 10.1016/j.brainresbull.2005.07.004. PMID 16182939. 
  • HYLAND, NP; CRYAN, JF. A Gut Feeling about GABA: Focus on GABA(B) Receptors.. Frontiers in Pharmacology. 2010, s. 124. DOI 10.3389/fphar.2010.00124. PMID 21833169. 
  • HILL, DR; BOWERY, NG. 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain.. Nature. 12 March 1981, s. 149–52. DOI 10.1038/290149a0. PMID 6259535. Bibcode 1981Natur.290..149H. 
  • Dzitoyeva S, Dimitrijevic N, Manev H. Gamma-aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: adult RNA interference and pharmacological evidence. Proc Natl Acad Sci USA. 2003, s. 5485–90. DOI 10.1073/pnas.0830111100. PMID 12692303. Bibcode 2003PNAS..100.5485D. 
  • Dimitrijevic N, Dzitoyeva S, Satta R, Imbesi M, Yildiz S, Manev H. Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB). Eur J Pharmacol. 2005, s. 246–52. DOI 10.1016/j.ejphar.2005.07.016. PMID 16129424. 
  • Manev H, Dimitrijevic N. Drosophila model for in vivo pharmacological analgesia research. Eur J Pharmacol. 2004, s. 207–8. DOI 10.1016/j.ejphar.2004.03.030. PMID 15140638. 
  • Dzitoyeva S, Gutnov A, Imbesi M, Dimitrijevic N, Manev H. Developmental role of GABAB(1) receptors in Drosophila. Brain Res Dev Brain Res. 2005, s. 111–4. DOI 10.1016/j.devbrainres.2005.06.005. PMID 16054235. 
  • Purves D., Augustine G.J., Fitzpatrick D., Katz L.C., LaMantia A.S., McNamara J.O., and Williams S.M. 2001. Neuroscience, Second Edition. Sinauer Associates, Inc.
  • Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, Kaupmann K. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharmacol.. November 2001, s. 963–71. Dostupné online. DOI 10.1124/mol.60.5.963. PMID 11641424. 
  • Adams CL, Lawrence AJ. CGP7930: a positive allosteric modulator of the GABAB receptor. CNS Drug Rev. 2007, s. 308–16. DOI 10.1111/j.1527-3458.2007.00021.x. PMID 17894647. 
  • Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A. Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J. Pharmacol. Exp. Ther.. July 2008, s. 306–14. DOI 10.1124/jpet.108.139204. PMID 18445779. 
  • Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, Kaupmann K. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J. Pharmacol. Exp. Ther.. October 2003, s. 322–30. DOI 10.1124/jpet.103.053074. PMID 12954816. 
  • Giotti A, Luzzi S, Spagnesi S, Zilletti L. Homotaurine: a GABAB antagonist in guinea-pig ileum.. Br. J. Pharmacol.. 1983, s. 855–62. DOI 10.1111/j.1476-5381.1983.tb10529.x. PMID 6652358. 
  • Kimura T, Saunders PA, Kim HS, Rheu HM, Oh KW, Ho IK. Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors. General Pharmacology. 1994, s. 193–9. DOI 10.1016/0306-3623(94)90032-9. PMID 8026706. 
  • Froestl W, Gallagher M, Jenkins H, Madrid A, Melcher T, Teichman S, Mondadori CG, Pearlman R. SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochemical Pharmacology. October 2004, s. 1479–87. DOI 10.1016/j.bcp.2004.07.030. PMID 15451390. 
  • Bullock R. SGS-742 Novartis. Current Opinion in Investigational Drugs. January 2005, s. 108–13. PMID 15675610. 

worldcat.org